CO4970811A1 - COMPUESTOS FARMACEUTICOS INHIBIDORES DEL ATPasa SENSIBLES A LA BAFILOMICINA Y PROCESO DE PREPARACION - Google Patents
COMPUESTOS FARMACEUTICOS INHIBIDORES DEL ATPasa SENSIBLES A LA BAFILOMICINA Y PROCESO DE PREPARACIONInfo
- Publication number
- CO4970811A1 CO4970811A1 CO98076414A CO98076414A CO4970811A1 CO 4970811 A1 CO4970811 A1 CO 4970811A1 CO 98076414 A CO98076414 A CO 98076414A CO 98076414 A CO98076414 A CO 98076414A CO 4970811 A1 CO4970811 A1 CO 4970811A1
- Authority
- CO
- Colombia
- Prior art keywords
- optionally substituted
- alkyl
- baphilomycin
- atpase
- sensitive
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 108091006112 ATPases Proteins 0.000 title 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- -1 hydroxy, amino Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005017 substituted alkenyl group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto de fórmula (I):o una sal del mismo, o un solvato del mismo, en la que:A representa un grupo arilo opcionalmente sustituido o un grupo heterociclilo opcionalmente sustituido; Ra representa -CO-NRS Rt , en la que RS y Rt , en cada caso independientemente, representan hidrógeno, alquilo, alquilo sustituido, alquenilo opcionalmente sustituido, arilo opcionalmente sustituido, arilalquilo opcionalmente sustituido, heterociclilo opcionalmente sustituido, o un grupo heterociclilalquilo opcionalmente sustituido, o RS y Rt junto con el nitrógeno al que están unidos juntos forman un grupo heterociclilo; R1 y R2 , en cada caso independientemente, representan hidrógeno, hidroxi, amino, alcoxi, ariloxi opcionalmente sustituido, benciloxi opcionalmente sustituido, alquilamino, dialquilamino, halo, trifluorometilo, trifluorometoxi, nitro, alquilo, carboxi, carbalcoxi, carbamoilo, alquilcarbamoilo, o R1 y R2 juntos representan metilendioxi, carbonilo o carbonildiamino; y R3 representa hidrógeno, alcanoílo, alquilo, aminoalquilo, hidroxialquilo, carboxialquilo, carbalcoxialquilo, carbamoílo o alquilsulfonilo y arilsulfonilo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97403154 | 1997-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4970811A1 true CO4970811A1 (es) | 2000-11-07 |
Family
ID=8229937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98076414A CO4970811A1 (es) | 1997-12-24 | 1998-12-23 | COMPUESTOS FARMACEUTICOS INHIBIDORES DEL ATPasa SENSIBLES A LA BAFILOMICINA Y PROCESO DE PREPARACION |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1042316B1 (es) |
| JP (1) | JP4627881B2 (es) |
| KR (1) | KR20010033528A (es) |
| CN (1) | CN1208333C (es) |
| AR (1) | AR018032A1 (es) |
| AT (1) | ATE288909T1 (es) |
| AU (1) | AU749319B2 (es) |
| BR (1) | BR9814403A (es) |
| CA (1) | CA2315723A1 (es) |
| CO (1) | CO4970811A1 (es) |
| DE (1) | DE69828998T2 (es) |
| ES (1) | ES2236971T3 (es) |
| HK (1) | HK1032953A1 (es) |
| HU (1) | HUP0100785A3 (es) |
| IL (1) | IL136720A0 (es) |
| NO (1) | NO320272B1 (es) |
| NZ (1) | NZ505060A (es) |
| PL (1) | PL191633B1 (es) |
| SA (1) | SA99200109B1 (es) |
| SI (1) | SI1042316T1 (es) |
| TR (1) | TR200001992T2 (es) |
| WO (1) | WO1999033822A1 (es) |
| ZA (1) | ZA9811758B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9914371D0 (en) * | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| GB9914825D0 (en) | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| AU2001247906A1 (en) * | 2000-03-31 | 2001-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted indoles and indazoles |
| US6872834B2 (en) | 2000-03-31 | 2005-03-29 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted indoles and indazoles |
| DE60128211T2 (de) | 2000-03-31 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituierte imidazopyridine |
| ITMI20040875A1 (it) * | 2004-04-30 | 2004-07-30 | Ist Naz Stud Cura Dei Tumori | Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali |
| US20090142832A1 (en) * | 2007-11-29 | 2009-06-04 | James Dalton | Indoles, Derivatives, and Analogs Thereof and Uses Therefor |
| AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
| JP6499306B2 (ja) * | 2014-10-24 | 2019-04-10 | ランドス バイオファーマ インコーポレイテッド | ランチオニンシンテターゼｃ様２系治療薬 |
| US11197891B2 (en) | 2017-11-30 | 2021-12-14 | Landos Biopharma, Inc. | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith |
| EP3927427B1 (en) | 2019-12-20 | 2024-02-07 | Nimmune Biopharma, Inc. | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3542827B2 (ja) * | 1994-07-15 | 2004-07-14 | 帝国臓器製薬株式会社 | 新規な５−置換イソキサゾール−３−カルボン酸アミド誘導体 |
| AU4536096A (en) * | 1995-01-10 | 1996-07-31 | Smithkline Beecham Spa | Indole derivatives useful in the treatment of osteoporosis |
| JP2002505689A (ja) * | 1997-06-19 | 2002-02-19 | セプレイコー インコーポレイテッド | キノリン−インドール抗菌剤、それらに関する用途及び組成物 |
| US6207679B1 (en) * | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
-
1998
- 1998-12-17 IL IL13672098A patent/IL136720A0/xx unknown
- 1998-12-17 EP EP98966951A patent/EP1042316B1/en not_active Expired - Lifetime
- 1998-12-17 WO PCT/EP1998/008561 patent/WO1999033822A1/en not_active Application Discontinuation
- 1998-12-17 PL PL341318A patent/PL191633B1/pl not_active IP Right Cessation
- 1998-12-17 JP JP2000526504A patent/JP4627881B2/ja not_active Expired - Fee Related
- 1998-12-17 HU HU0100785A patent/HUP0100785A3/hu unknown
- 1998-12-17 ES ES98966951T patent/ES2236971T3/es not_active Expired - Lifetime
- 1998-12-17 BR BR9814403-0A patent/BR9814403A/pt not_active Application Discontinuation
- 1998-12-17 CN CNB988137917A patent/CN1208333C/zh not_active Expired - Fee Related
- 1998-12-17 DE DE69828998T patent/DE69828998T2/de not_active Expired - Fee Related
- 1998-12-17 SI SI9830765T patent/SI1042316T1/xx unknown
- 1998-12-17 KR KR1020007007030A patent/KR20010033528A/ko not_active Application Discontinuation
- 1998-12-17 NZ NZ505060A patent/NZ505060A/xx unknown
- 1998-12-17 CA CA002315723A patent/CA2315723A1/en not_active Abandoned
- 1998-12-17 AU AU27154/99A patent/AU749319B2/en not_active Ceased
- 1998-12-17 TR TR2000/01992T patent/TR200001992T2/xx unknown
- 1998-12-17 AT AT98966951T patent/ATE288909T1/de not_active IP Right Cessation
- 1998-12-22 AR ARP980106609A patent/AR018032A1/es unknown
- 1998-12-22 ZA ZA9811758A patent/ZA9811758B/xx unknown
- 1998-12-23 CO CO98076414A patent/CO4970811A1/es unknown
-
1999
- 1999-05-11 SA SA99200109A patent/SA99200109B1/ar unknown
-
2000
- 2000-06-23 NO NO20003315A patent/NO320272B1/no unknown
-
2001
- 2001-03-15 HK HK01101878A patent/HK1032953A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003532616A (ja) | 2003-11-05 |
| EP1042316A1 (en) | 2000-10-11 |
| PL341318A1 (en) | 2001-04-09 |
| AU2715499A (en) | 1999-07-19 |
| HK1032953A1 (en) | 2001-08-10 |
| ATE288909T1 (de) | 2005-02-15 |
| ES2236971T3 (es) | 2005-07-16 |
| HUP0100785A2 (hu) | 2001-08-28 |
| SA99200109B1 (ar) | 2006-09-13 |
| CN1299357A (zh) | 2001-06-13 |
| DE69828998D1 (de) | 2005-03-17 |
| AU749319B2 (en) | 2002-06-20 |
| WO1999033822A1 (en) | 1999-07-08 |
| ZA9811758B (en) | 2000-06-22 |
| NO20003315D0 (no) | 2000-06-23 |
| TR200001992T2 (tr) | 2001-01-22 |
| JP4627881B2 (ja) | 2011-02-09 |
| PL191633B1 (pl) | 2006-06-30 |
| CA2315723A1 (en) | 1999-07-08 |
| KR20010033528A (ko) | 2001-04-25 |
| HUP0100785A3 (en) | 2001-09-28 |
| BR9814403A (pt) | 2000-10-10 |
| NO20003315L (no) | 2000-06-23 |
| SI1042316T1 (es) | 2005-08-31 |
| CN1208333C (zh) | 2005-06-29 |
| NO320272B1 (no) | 2005-11-14 |
| EP1042316B1 (en) | 2005-02-09 |
| AR018032A1 (es) | 2001-10-31 |
| DE69828998T2 (de) | 2006-05-04 |
| NZ505060A (en) | 2002-09-27 |
| IL136720A0 (en) | 2001-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE46699A1 (es) | Compuesto derivado de indol | |
| SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| CO4960662A1 (es) | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados | |
| LU90991I2 (fr) | Tamiflu ses sels et dérivés pharmaceutiquement acceptables | |
| CO4970811A1 (es) | COMPUESTOS FARMACEUTICOS INHIBIDORES DEL ATPasa SENSIBLES A LA BAFILOMICINA Y PROCESO DE PREPARACION | |
| MX9303263A (es) | Antagonistas de la angiotensina ii, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen | |
| BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
| DE69309540T2 (de) | Orale Arzneimittel mit kolonspezifischer Freisetzung | |
| AR042273A1 (es) | Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen | |
| EA199700098A1 (ru) | Производные индола, пригодные для лечения остеопороза | |
| AR039399A1 (es) | Compuestos quimicos con actividad doble, procedimientos para su preparacion y composiciones farmaceuticas | |
| NO980178L (no) | Cyklo-oksygenase-inhibitor og amidin-derivatsalter, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater | |
| BR0114380A (pt) | Derivados-1-aminobutan-3-ol-substituìdos | |
| FI970434A0 (fi) | Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä | |
| MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
| IS5390A (is) | Bensoxazín og bensóþíazín afleiður og notkun þeirra í lyf | |
| DK1017681T3 (da) | Hydrazon-benzazulenderivater, farmaceutiske præparater og mellemprodukter | |
| EA200000532A3 (ru) | НОВЫЕ СОЕДИНЕНИЯ 7-ОКСО-2,3,7,14-ТЕТРАГИДРО-1H-БЕНЗО[b]-ПИРАНО [3,2-h]АКРИДИНКАРБОКСИЛАТА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
| BR0114459A (pt) | Derivados substituìdos de 5-amino-1-penten-3-ol substituidos | |
| EA200401617A1 (ru) | Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера | |
| CO4890845A1 (es) | Derivados de 2,3-indol | |
| EA199901049A2 (ru) | Спироимидазолиновые соединения, способ их получения и фармацевтическая композиция, содержащая их | |
| HU9202849D0 (en) | Method for producing n,n',n-trisubstituted- 5-bis-amino-methylene-1,3-dioxane-4,6-dione derivatives and pharmaceutical preparatives containing them | |
| DE69708265T2 (de) | Benzimidazol phosphono-aminosäure | |
| TH66556A (th) | สารยับยั้งเมททัลโลโพรทีเนส สไพโร-ไพริมิดีน-2,4,6-ไตรโอน |